세계의 의약품 레퍼런스 앱 시장 보고서(2025년)
Drug Reference Apps Global Market Report 2025
상품코드 : 1889367
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,718,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,710,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,703,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의약품 레퍼런스 앱 시장의 규모는 최근 급속도로 확대되고 있습니다. 2024년의 13억 7,000만 달러에서 2025년에는 15억 5,000만 달러로, CAGR 12.8%로 성장할 전망입니다. 지난 수년간의 성장은 신뢰할 수 있는 의약품 정보의 필요성을 높이는 약물 오용 사고 증가, 의료 종사자의 스마트폰 보급 확대, 환자 안전 및 유해 사례 예방에 대한 중점 강화, 디지털 의료 툴의 인지도 향상, 근거 기반 임상 판단에 대한 의존도 상승, 온라인 의약품 레퍼런스의 광범위한 가용성 등의 요인에 의해 발생하였습니다.

의약품 레퍼런스 앱 시장의 규모는 향후 수년간 높은 성장이 예상되고 있습니다. 2029년에는 24억 8,000만 달러에 달하고, CAGR은 12.4%로 예측되고 있습니다. 예측 기간의 성장 요인으로는 모바일 포인트 오브 케어 툴의 이용 증가, 복잡한 약물 요법과 병용 치료의 증가, 원격 의료 서비스의 보급 확대, 빈번한 약제 확인을 필요로 하는 만성 질환 환자의 급증, 환자에 의한 자가 투약에 대한 관심 증가 등을 들 수 있습니다. 예측 기간의 주요 동향으로는 실시간 약제 상호작용 검출 기술의 진보, 다언어 및 지역 특화형 약제 데이터베이스의 진전, AI를 활용한 약제 안전성 경고의 혁신, 음성 인식형 임상 검색 툴의 연구 개발, 의료 종사자용 클라우드 기반 공동 작업 기능의 향상 등을 들 수 있습니다.

스마트폰 보급의 확대가 의약품 레퍼런스 앱 시장의 성장을 견인하고 있습니다. 인터넷 연결과 실시간 통신 기능을 갖춘 첨단 모바일 장치인 스마트폰은 모바일 인터넷 액세스가 확대됨에 따라 점점 더 보급되고 있습니다. 이 보급으로 의료 종사자와 환자는 언제 어디서나 의약품 레퍼런스 앱에 액세스할 수 있어 즉각적인 의약품 정보, 상호작용 확인, 복용 지침을 제공함으로써 효율성이 향상되고 있습니다. 예를 들어(2024년) 11월에 유로스타트가 발표한 데이터에 의하면, 2023년 시점에서 EU 내의 16-74세의 도시 거주자의 89%가 스마트폰으로 인터넷을 이용하고 있었으며, 마을이나 교외에서는 86%, 농촌에서는 82%였습니다. 이 광범위한 스마트폰 사용은 중요한 약물 정보에 대한 실시간 액세스를 지원하고 시장 성장을 가속합니다.

시장의 주요 기업은 약물의 안전성과 처방 정밀도를 높이는 AI 탑재 모듈을 개발 중입니다. 이 모듈은 인공지능을 활용하여 데이터 분석, 약물 상호 작용 검출, 약물 제안 및 임상 판단을 지원합니다. 예를 들어, 2025년 9월에는 미국에 본사를 둔 의약품 레퍼런스 앱을 제공하는 기업인 Epocrates가 대화형 AI 어시스턴트를 출시했습니다. 이 회사의 모바일 앱에 통합된 AI 도구를 통해 임상의는 치료법 비교 및 금기 확인 등 의약품에 대한 복잡한 질문을 던지고 신뢰할 수 있는 의약품 데이터베이스에서 간결하고 실용적인 답변을 얻을 수 있습니다. 이는 수동 검색의 필요성을 줄이고, 진료 현장에서 보다 안전한 처방 능력을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Drug reference apps are digital tools that provide detailed information about medications, including their indications, dosages, side effects, interactions, and contraindications. They serve healthcare professionals, students, and patients by offering quick, reliable, and easily accessible drug data. These apps help support safe prescribing, dispensing, and medication administration, reducing the likelihood of errors and improving overall patient care.

The primary functionalities of drug reference apps include drug interaction checking, dosage information, side effect and warning details, patient information leaflets, and medication management tools. Drug interaction checking is a feature that alerts users to potentially harmful interactions between multiple medications, substances, or medical conditions. Pricing models include free apps, subscription-based plans, one-time purchase options, freemium models, and enterprise licenses for organizations, accessible through smartphones and tablets. Key application types include standalone apps, integrated systems (such as electronic medical records (EMR) or electronic health records (EHR)), web-based applications, mobile applications, and desktop applications, serving end users such as healthcare professionals, patients, pharmacists, researchers, educators, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The drug reference apps market research report is one of a series of new reports from The Business Research Company that provides drug reference apps market statistics, including the drug reference apps industry global market size, regional shares, competitors with the drug reference apps market share, detailed drug reference apps market segments, market trends, and opportunities, and any further data you may need to thrive in the drug reference apps industry. This drug reference apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug reference apps market size has grown rapidly in recent years. It will grow from $1.37 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. Growth during the historic period can be linked to rising medication errors that increased the need for reliable drug information, growing smartphone adoption among healthcare professionals, greater emphasis on patient safety and adverse event prevention, expanding awareness of digital healthcare tools, increasing reliance on evidence-based clinical decision-making, and broader availability of online drug references.

The drug reference apps market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. Growth in the forecast period can be attributed to the rising use of mobile point-of-care tools, an increasing number of complex drug therapies and combination treatments, growing adoption of telemedicine services, a surge in chronic disease cases requiring frequent medication checks, and a heightened focus on self-medication among patients. Key trends anticipated for the forecast period include technological advancements in real-time drug interaction detection, progress in multilingual and region-specific drug databases, innovations in AI-enabled drug safety alerts, research and development in voice-activated clinical search tools, and advancements in cloud-based collaboration features for healthcare providers.

The increasing adoption of smartphones is driving the growth of the drug reference apps market. Smartphones-advanced mobile devices with internet connectivity and real-time communication capabilities-are becoming increasingly prevalent due to the expansion of mobile internet access. This adoption allows healthcare professionals and patients to access drug reference apps anytime and anywhere, improving efficiency by providing instant drug information, interaction checks, and dosage guidance. For example, in November 2024, Eurostat reported that 89% of EU residents aged 16-74 living in cities used smartphones to access the internet in 2023, compared with 86% in towns and suburbs and 82% in rural areas. This widespread smartphone usage supports real-time access to vital drug information, boosting market growth.

Key companies in the market are developing AI-powered modules to enhance medication safety and prescribing accuracy. These modules leverage artificial intelligence to analyze data, detect drug interactions, suggest medications, and support clinical decisions. For instance, in September 2025, Epocrates, a US-based drug reference app provider, launched a Conversational AI Assistant. Integrated into its mobile app, this AI tool allows clinicians to ask complex questions about medications-such as comparing treatments or checking for contraindications-and receive concise, actionable answers from a trusted drug database, reducing the need for manual searches and enabling safer prescribing at the point of care.

In March 2024, First Databank Inc., a US-based healthcare technology company, partnered with WebMD Ignite Inc. to enhance patient medication safety and adherence by incorporating FDB's medication education content into WebMD Ignite's platform, combining trusted information with accessible digital delivery for healthcare professionals and patients.

Major companies operating in the drug reference apps market are Hearst Corporation, Wolters Kluwer Health, Athenahealth Inc., WebMD LLC, Haymarket Media Group, Merative US L.P., ConnectiveRx, F.A. Davis Company, Drugs.com, Medscape, RxList Inc., Canadian Pharmacists Association, Skyscape Medpresso Inc., Jones & Bartlett Learning, MyTherapy GmbH, Antimicrobial Therapy Inc., MIMS Group, CIMS Medica India Private Limited, PEPID LLC, Australian Medicines Handbook Pty Ltd

North America was the largest region in the drug reference apps market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug reference apps report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug reference apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug reference apps market consists of revenues earned by entities by providing services such as clinical decision support, drug database updating, adverse event reporting, formulary management, medication verification services, and medical content licensing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug reference apps market also includes sales of drug information databases, pill identifier tools, dosage calculation tools, barcode scanning tools, offline drug reference modules, and multilingual drug content packs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Reference Apps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug reference apps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for drug reference apps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug reference apps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Drug Reference Apps Market Characteristics

3. Drug Reference Apps Market Trends And Strategies

4. Drug Reference Apps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Drug Reference Apps Growth Analysis And Strategic Analysis Framework

6. Drug Reference Apps Market Segmentation

7. Drug Reference Apps Market Regional And Country Analysis

8. Asia-Pacific Drug Reference Apps Market

9. China Drug Reference Apps Market

10. India Drug Reference Apps Market

11. Japan Drug Reference Apps Market

12. Australia Drug Reference Apps Market

13. Indonesia Drug Reference Apps Market

14. South Korea Drug Reference Apps Market

15. Western Europe Drug Reference Apps Market

16. UK Drug Reference Apps Market

17. Germany Drug Reference Apps Market

18. France Drug Reference Apps Market

19. Italy Drug Reference Apps Market

20. Spain Drug Reference Apps Market

21. Eastern Europe Drug Reference Apps Market

22. Russia Drug Reference Apps Market

23. North America Drug Reference Apps Market

24. USA Drug Reference Apps Market

25. Canada Drug Reference Apps Market

26. South America Drug Reference Apps Market

27. Brazil Drug Reference Apps Market

28. Middle East Drug Reference Apps Market

29. Africa Drug Reference Apps Market

30. Drug Reference Apps Market Competitive Landscape And Company Profiles

31. Drug Reference Apps Market Other Major And Innovative Companies

32. Global Drug Reference Apps Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Reference Apps Market

34. Recent Developments In The Drug Reference Apps Market

35. Drug Reference Apps Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기